Literature DB >> 1507221

Alu RNA transcripts in human embryonal carcinoma cells. Model of post-transcriptional selection of master sequences.

D Sinnett1, C Richer, J M Deragon, D Labuda.   

Abstract

Alu master sequences colonized the human genome using RNA as amplification intermediate. To understand this phenomenon better we isolated and analyzed Alu RNA from NTera2D1 pluripotential cells. Northern hybridization, primer extension, cDNA cloning and sequencing data are congruent and demonstrate a low level of Alu specific transcription. These bona fide RNA Polymerase III Alu transcripts, although enriched in the cytoplasm, are not dominated by a single master species but rather originate from a variety of loci. However, when compared with the genomic average, or to repeats from RNA Polymerase II co-transcripts, they belong to the youngest group of Alu subfamilies (p less than 0.001) and have a higher content of intact CpG-dinucleotides. This suggests that Alu transcription is influenced both by mutations and the genomic context, and points to a possible role of DNA methylation in silencing the bulk of genomic repeats. Because of the heterogeneity of Alu transcripts a post-transcriptional selection mechanism recruiting Alu master sequences for retroposition is required. We propose that Alu RNA masters could have evolved as selfish satellites to a more complex retroposition system equipped with a reverse transcriptase activity and that their structure was conserved through "phenotypic" selection of the RNA level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1507221     DOI: 10.1016/0022-2836(92)90626-u

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  35 in total

1.  Cis-acting influences on Alu RNA levels.

Authors:  C Alemán; A M Roy-Engel; T H Shaikh; P L Deininger
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

2.  K562 cells implicate increased chromatin accessibility in Alu transcriptional activation.

Authors:  T H Li; C Kim; C M Rubin; C W Schmid
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Potential for retroposition by old Alu subfamilies.

Authors:  Karla Johanning; Claudina Alemán Stevenson; Oluwatosin O Oyeniran; Yair M Gozal; Astrid M Roy-Engel; Jerzy Jurka; Prescott L Deininger
Journal:  J Mol Evol       Date:  2003-06       Impact factor: 2.395

4.  Synthesis and processing of tRNA-related SINE transcripts in Arabidopsis thaliana.

Authors:  Thierry Pélissier; Cécile Bousquet-Antonelli; Laurence Lavie; Jean-Marc Deragon
Journal:  Nucleic Acids Res       Date:  2004-07-28       Impact factor: 16.971

5.  Laboratory methods for the analysis of primate mobile elements.

Authors:  David A Ray; Kyudong Han; Jerilyn A Walker; Mark A Batzer
Journal:  Methods Mol Biol       Date:  2010

6.  Monomeric scAlu and nascent dimeric Alu RNAs induced by adenovirus are assembled into SRP9/14-containing RNPs in HeLa cells.

Authors:  D Y Chang; K Hsu; R J Maraia
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

7.  An analysis of retroposition in plants based on a family of SINEs from Brassica napus.

Authors:  J M Deragon; B S Landry; T Pélissier; S Tutois; S Tourmente; G Picard
Journal:  J Mol Evol       Date:  1994-10       Impact factor: 2.395

8.  Multiple dispersed loci produce small cytoplasmic Alu RNA.

Authors:  R J Maraia; C T Driscoll; T Bilyeu; K Hsu; G J Darlington
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  A human Alu RNA-binding protein whose expression is associated with accumulation of small cytoplasmic Alu RNA.

Authors:  D Y Chang; B Nelson; T Bilyeu; K Hsu; G J Darlington; R J Maraia
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR.

Authors:  E Zietkiewicz; M Labuda; D Sinnett; F H Glorieux; D Labuda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.